BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomes.
Lee J, Ahmed T, Maurichi A, Di Guardo L, Stagno AM, Warburton L, Taylor AM, Livingstone E, Rehman S, Khattak A, Kahler KC, Vanella V, Atkinson V, Millward M, Schadendorf D, Johnson DB, Ascierto PA, Hauschild A, Lo SN, Long GV, Menzies AM, Carlino MS.
Lee J, et al. Among authors: stagno am.
Eur J Cancer. 2023 Jan;179:87-97. doi: 10.1016/j.ejca.2022.11.009. Epub 2022 Nov 12.
Eur J Cancer. 2023.
PMID: 36509002